Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

Share Price is delayed by 15 minutes
Get Live Data
9.00    0.00 (0.00%)
Bid:
7.00
Ask:
11.00
Spread: 4.00 (57.143%)
Market Cap: £2.98m
HYG Live PriceLast checked at - London Stock Exchange

Intraday Seneca Growth Share Chart

Interim Management Statement

15 May 2008 07:00

RNS Number : 4740U
Hygea VCT plc
15 May 2008
 



FOR IMMEDIATE RELEASE  15 MAY 2008

HYGEA VCT PLC

INTERIM MANAGEMENT STATEMENT 

Hygea VCT plc ("Hygea" or the "Company") presents its interim management statement for the period from 1 January 2008 to 14 May 2008 (the "Period"). This constitutes the Company's first interim management statement for the financial year ending 31 December 2008, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3. This statement has been prepared solely to provide additional information in order to meet the requirements of the Disclosure and Transparency Rules and should not be relied on by shareholders, or any other party, for any other purpose.

The unaudited net asset value per ordinary share and the number of shares in issue at 31 March 2008 were 60.3p and 7,530,191 respectively (31 December 2007: 61.2p and 7,530,191 respectively).

On 2 April 2008 and 30 April 2008, a total of 150,000 new ordinary shares have been allotted at a price of 50p pursuant to the 10% top-up offer announced on 19 March 2008.

During the three months ended 31 March 2008 the company subscribed for further shares in Prosurgics Limited (a leading image-guided surgical robotics company) at a total cost of £100,000 and in Hallmarq Veterinary Imaging Limited (which develops low cost magnetic resonance imaging systems for equine vets) at a total cost of £100,000 and has made no disposals.

The Directors note that the net asset value has fallen in the three months ended 31 March 2008 largely due to the decline in the value of the, albeit reduced, AIM portfolio as well as operating expenses in the period. The Directors remain confident that the portfolio will deliver value to shareholders over the three to five year period referred to in the annual report based on positive operating developments within the portfolio.

The Directors are not aware of any events which have taken place between 31 March 2008 and the date of publication of this statement, which have had a material effect on the financial position of the company.

Enquiries: 

James Otter, Chairman, Hygea VCT plc - james.otter@ellipson.co.uk 

Neil OsmondCompany Secretary, Hygea VCT plc on 020 7866 5420

website: www.hygeavct.com

Roland Cornish/Felicity Geidt, Beaumont Cornish Limited - 0207 628 3396

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUSVVRWURVAAR
Date   Source Headline
28th Apr 202110:52 amGNWIssue of Equity and Total Voting Rights
1st Apr 20215:29 pmGNWDirector/PDMR Shareholding
1st Apr 202111:36 amGNWIssue of Equity and TVR
31st Mar 20217:00 amGNWNet Asset Value(s)
29th Mar 20215:12 pmGNWResult of AGM
4th Mar 20215:26 pmGNWDirector/PDMR Shareholding
2nd Mar 202112:50 pmGNWIssue of Equity and Total Voting Rights
24th Feb 20211:49 pmGNWIssue of Prospectus
23rd Feb 20217:00 amGNWFinal Results and NAV Update
18th Feb 20217:00 amGNWDividend Declaration
10th Dec 20203:57 pmGNWDirector/PDMR Shareholding
9th Dec 20203:49 pmGNWIssue of Equity and Total Voting Rights
5th Nov 20207:00 amGNWDividend Declaration
13th Oct 20204:22 pmGNWOffer for Subscription
5th Oct 20207:00 amGNWSecond Interim Capital Dividend
5th Oct 20207:00 amGNWNAV Update
16th Sep 20207:00 amGNWInvestment Realisations and NAV
21st Aug 202010:55 amGNWChange of Registered Office
30th Jul 20207:00 amGNWHalf-year report
10th Jul 202011:43 amGNWIssue of Equity
24th Jun 202012:35 pmGNWB Share - Extension of Offer
13th May 20203:03 pmGNWPublication of a supplementary prospectus
29th Apr 202012:45 pmGNWIssue of Equity
29th Apr 20207:00 amGNWResult of Annual General Meeting
27th Apr 20206:52 pmGNWUpdate on Omega, Optibiotix and NAVs
20th Apr 20206:36 pmGNWOmega Diagnostics, Net Asset Value, New B Share Pool Investments
7th Apr 20204:35 pmGNWIssue of Supplementary Prospectus
3rd Apr 20202:10 pmGNWIssue of Equity
31st Mar 20205:30 pmGNWNet Asset Value(s)
26th Mar 20204:31 pmGNWAGM Venue Change
13th Mar 20204:14 pmGNWInterim Dividend
10th Mar 20202:28 pmGNWIssue of Equity
10th Mar 20207:00 amGNWB Share Net Asset Value
3rd Mar 20204:30 pmGNWIssue of Supplementary Prospectus
27th Feb 20207:00 amGNWFinal Results
9th Dec 20195:45 pmGNWDirectorate Change
27th Nov 20192:45 pmGNWIssue of Equity
20th Nov 20194:00 pmGNWDuplicate: Second Interim Dividend
28th Oct 20197:00 amGNWSecond interim dividend
10th Oct 20196:30 pmGNWDirector/PDMR Shareholding
8th Oct 20191:55 pmGNWIssue of Equity
8th Oct 20197:00 amGNWUpdate for the quarter ended 30 September 2019
17th Jul 20198:00 amGNWCorrection: Offer for Subscription
16th Jul 20195:27 pmGNWOffer for Subscription
10th Jul 20195:20 pmGNWHalf-year report
18th Jun 20199:16 amRNSHolding(s) in Company
10th Jun 20196:14 pmRNSResult of AGM
16th May 20197:00 amRNSSecond Interim Dividend
29th Apr 20198:52 amRNSFinal Results
25th Apr 20197:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.